Checkpoint Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CKPT and other ETFs, options, and stocks.About CKPT
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.
CEOJames F. Oliviero
CEOJames F. Oliviero
Employees23
Employees23
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2014
Founded2014
Employees23
Employees23
CKPT Key Statistics
Market cap56.74M
Market cap56.74M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume334.14K
Average volume334.14K
High today$1.70
High today$1.70
Low today$1.47
Low today$1.47
Open price$1.48
Open price$1.48
Volume619.33K
Volume619.33K
52 Week high$3.62
52 Week high$3.62
52 Week low$1.30
52 Week low$1.30